Table of Contents

company-logo

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Molecular Templates Dividend Announcement

• Molecular Templates does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Molecular Templates dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Molecular Templates Dividend History

Molecular Templates Dividend Yield

Molecular Templates current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Molecular Templates stock? Use our calculator to estimate your expected dividend yield:

Molecular Templates Financial Ratios

P/E ratio-0.36
PEG ratio-0.03
P/B ratio0.37
ROE-122.03%
Payout ratio0.00%
Current ratio1.56
Quick ratio1.56
Cash Ratio1.26

Molecular Templates Dividend FAQ

Does Molecular Templates stock pay dividends?
Molecular Templates does not currently pay dividends to its shareholders.
Has Molecular Templates ever paid a dividend?
No, Molecular Templates has no a history of paying dividends to its shareholders. Molecular Templates is not known for its dividend payments.
Why doesn't Molecular Templates pay dividends?
There are several potential reasons why Molecular Templates would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Molecular Templates ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Molecular Templates has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Molecular Templates a dividend aristocrat?
Molecular Templates is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Molecular Templates a dividend king?
Molecular Templates is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Molecular Templates a dividend stock?
No, Molecular Templates is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Molecular Templates stocks?
To buy Molecular Templates you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Molecular Templates stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.